Follow the 부광약품 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 부광약품 has recorded 43 reports. The latest transaction was disclosed on 1 July 2025 (Sale). Among the most active insiders: OCI홀딩스. All data is accessible without an account.
43
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
5 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.